Columbia University College of Physicians and Surgeons, the Joseph L. Mailman School of Public Health, Columbia University, and the Herbert Irving Comprehensive Cancer Center, New York Presbyterian Hospital, New York, New York; Massachusetts General Hospital, Boston, Massachusetts; and Rutgers Robert Wood Johnson Medical School; and the Environmental and Occupational Health Sciences Institute (EOHSI), Piscataway, New Jersey.
Corresponding author: Jason D. Wright, MD, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, 161 Fort Washington Ave, 8th Floor, New York, NY 10032; email: [email protected].
Dr. Wright (NCI R01CA169121-01A1) is the recipient of a grant from the National Cancer Institute. Dr. Hershman is the recipient of a grant from the Breast Cancer Research Foundation-Conquer Cancer Foundation.
Financial Disclosure Dr. Wright has served as a consultant for Tesaro and Clovis Oncology. Dr. Neugut has served as a consultant to Pfizer, Teva, Otsuka, Hospira, and United Biosource Corporation. He is on the scientific advisory board of EHE, Intl. The other authors did not report any potential conflicts of interest.
Each author has confirmed compliance with the journal's requirements for authorship.
Peer reviews are available at https://links.lww.com/AOG/B383.